Long COVID comes in three forms: study – The Hill

The story at a glance


  • New research from scientists at King’s College London supports the idea that there are three different types of long COVID, each with their own symptoms.

  • Researchers studied more than 1,000 people with post-COVID syndrome and found that there are three different subtypes of the condition.

  • The first subtype included respiratory symptoms, the second neurological, and the third autoimmune.

According to the researchers, there are three different types of long COVID, each with its own set of symptoms.

In a new pre-print study, meaning it has not yet been peer reviewed, on MedRxiv, a site that distributes unpublished research in the health sciences, scientists from King’s College London analyzed the experiences of thousands of people across the UK who have been infected with the virus.

The researchers focused on 1,459 people living with post-COVID syndrome – who study craftsmen defined as showing symptoms for at least 12 weeks after being infected with the virus – and were able to place the patients into three main “profiles of symptoms”.


Our country is in a historic fight against the coronavirus. Add Change America to your Facebook Where Twitter stream to stay up to date with the news.


PCS patients – who are also colloquially referred to as long COVID patients – placed in the first group suffered from respiratory symptoms like chest pain and shortness of breath or palpitations.

The second group was made up of long-term COVID patients who exhibited neurological symptoms like fatigue, brain fog, poor memory and headaches, which the researchers said were most often experienced by those who had been infected with the alpha or delta variants, depending on the study.

The third group was made up of people who had an immune system-related response, according to the study.

More than 7% of all American adults currently have symptoms of long COVID, according to data from the Census Bureau. But while thousands of people suffer from this condition, not much is known about how to treat it.

While further work is needed to confirm the study’s findings, it offers insight into the complexities of the virus and its impact on human health.

“This information could aid in the development of personalized diagnosis and treatment, as well as help policy makers plan the delivery of care for people living with post-COVID syndrome,” the study says.


READ MORE STORIES FROM AMERICA IN CHANGE

THOUSANDS OF REPORTS OF CHANGES IN MENSTRUAL BLEEDING AFTER COVID-19 VACCINE, STUDY SHOWS

WHAT YOU NEED TO KNOW ABOUT THE NEW NOVAVAX VACCINE AGAINST COVID-19

HEALTH EXPERTS URGE PARENTS WHO TRAVEL WITH CHILDREN TO CONTINUE WEARING MASKS, REMEMBER NOT TO TAKE FLIGHTS

OMICRON LASTS LONGER ON SURFACES AND SKIN THAN PREVIOUS VARIANTS: STUDIES

BA.2 OMICRON SUBVARIATING NEARLY 35 PERCENT OF CORONAVIRUS CASES IN THE UNITED STATES

Posted on August 03, 2022

Leave a Comment